ImmunoACT - Company Profile & Overview
Founded in 2018, ImmunoACT operates in Health Tech offering gene-modified cell therapies, specifically CAR-T cell therapy for treating certain B-cell malignancies. The company was spun out from IIT-Bo...
Funding stage:
Corporate Round
Last funding:
30/05/2023
Total funding:
$17.18 Mn+
Revenue:
Investors
Employee count:
192
Last 90d
192
Last 90d
Web traffic:
3.51K
3.51K
Last 30d
Last 30d
Glassdoor Rating:
FAQs on ImmunoACT
ImmunoACT was founded by Rahul Purwar,Atharva Karulkar in 2018.
Health Tech startup ImmunoACT has raised a total funding of $17.18 million across 2 funding rounds. The last round of funding was raised on 31 May 2023. Find the details around funding rounds, participating investors, and other insights of ImmunoACT here...
ImmunoACT is a company based in Navi Mumbai, Maharashtra, India, operating in the health tech sector. Founded in 2018, it now employs 88 individuals. The company was established by Rahul Purwar,Atharva Karulkar.
ImmunoACT reported revenue of ₹67.6 Cr in FY25, an increase of 509.7% from FY24 (₹11.1 Cr).
ImmunoACT is headquartered in Mumbai, India.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links